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FFR and Coronary Flow Reserve
Friends or Foes?*
Heinrich R. Schelbert, MD, PHD
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pThe FAME (Fractional Flow Reserve Versus An-
giography for Multivessel Evaluation) study has
re-emphasized the importance of assessing func-
tional consequences of coronary stenoses (1,2). In
that multicenter trial involving 1,005 patients with
multivessel coronary artery disease (CAD), percu-
taneous coronary interventions (PCI) guided by
functional assessments of coronary stenoses was associ-
ated with a significantly lower 2-year morbidity and
See page 193
mortality as compared to PCI guided only by
coronary anatomy (1,2). The functional assessments
were based on the fractional flow reserve (FFR), an
invasive approach, which measures the stenosis-
related decline in distal coronary pressure during
maximum hyperemia. The normal coronary vessel
exerts little if any resistance to flows even during
hyperemia, so that the coronary pressure is fully
maintained throughout the length of the epicardial
coronary artery and the distal coronary pressure
equals the central aortic pressure. In the presence of
a focal coronary stenosis, however, the distal coro-
nary pressure declines during hyperemia as a func-
tion of the stenosis severity; stenoses with FFRs
0.75 or 0.80 have been shown to induce isch-
emia and, hence, are defined as functionally signif-
icant. Methodologically, the FFR depends only on
the distal to proximal pressure difference in the
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f heart rate and blood pressure (3). It thus differs
rom other measures of functional significance of
oronary stenosis like the coronary flow reserve
CFR) or stress-rest myocardial perfusion imaging
MPI), which compare hyperemic to resting flows
r evaluate the effects of coronary stenosis on the
elative distribution of myocardial blood flow.
Nevertheless, estimates of the functional signifi-
ance of coronary stenoses by different techniques
ould be expected to be comparable. Indeed, initial
omparison studies reported closely correlated val-
es of FFR and MPI in patients with mostly
ingle-vessel disease (4), yet, this agreement no
onger holds for comparisons in patients with mul-
ivessel disease. For instance, FFR and MPI find-
ngs agreed in only about 40% of patients with 2- or
-vessel disease (5,6), mostly because MPI was
ound to underestimate the extent of CAD. The
ack of agreement was not necessarily surprising;
alues of FFR reflect the downstream pressure
radient in a given coronary artery whereas MPI
ompares the functional stenosis severity between
oronary vessels; namely, stress-induced perfusion
efects are related to the myocardial region with the
ighest perfusion, assuming that the upstream cor-
nary artery is normal when in fact it is also
requently diseased although less severely than the
omparison vessels.
In contrast, assessments of the stenosis severity
y CFR do not depend on such intervessel com-
arison but on the maximum achievable flow rela-
ive to baseline flow in the very same vessel. Esti-
ates by CFR would, therefore, be expected to
gree well with those by FFR. Initial comparison
tudies again reported such close correlation (7).
et, the findings in that study were based on
atients with mostly single-vessel disease; subse-
uent investigations in patients with multivessel
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204disease failed to confirm such close agreement; in
fact, substantial disagreements between both mea-
surements were noted (8,9). These disparities are at
the center of the elegant studies by Johnson et al.
(10) as reported in this issue of the iJACC.
The investigators seek to answer the question
whether the disparity in measured indexes results
from methodological shortcomings or is explained
by disease-related disturbances of the coronary cir-
culatory function. Collecting all reported intrapa-
tient comparisons of CFR and FFR, they find a
statistically significant, but only modest correlation
between both measures of stenosis function, and
thus reconfirm the limited concordance of the 2
functional parameters. In a second step, Johnson et
al. (10) compare in 1,500 consecutive studies, per-
formed in their own institution, qualitative Rb-82
positron emission tomography evaluations of stress-
induced perfusion defects and CFRs. Again, they
find a similarly modest although statistically signif-
icant correlation between both measures of coronary
function. Two possible explanations for the ob-
served disparities emerge: 1) disease of the “normal
reference vessel” as would be expected for MPI; and
2) diffuse disease of the epicardial conduit vessel or
isolated disease of the coronary microvasculature, or
both. The potential implications of diffuse disease
and of microvascular function on the CFR and
the FFR are then tested in a theoretical model of
varying degrees of diffuse conduit vessel disease
with a single focal proximal left anterior descend-
ing coronary artery lesion superimposed. In ad-
dition to the actual stenosis severity, the model
identifies diffuse conduit vessel disease and dis-
ease of the resistance vessels as significant con-
tributors to observed FFR values. Importantly,
although suspected previously (11) but now ar-
ticulated more clearly by Johnson et al. (10), the
fluid-dynamic effect of a discrete stenosis can
only be fully appreciated if the resistance along
the conduit vessel and of the microvessels is
maximally reduced, or, in other words, if true
maximum hyperemia can be achieved (12).
The investigators present compelling arguments
for why maximum hyperemic flows are frequently
not achieved so that FFRs often do not fully reflect
the true functional impact of focal coronary lesions.
Specifically, they point out that CFRs reported in
the literature for angiographically “normal” vessels
in patients with CAD are substantially lower than
those in young normal volunteers, an observation
the researchers attribute to diffuse epicardial coro-
nary disease and/or microvascular disturbances thatthey assume to involve also those vessels with focal
stenosis and that attenuate the hyperemic response
to pharmacological vasodilation. Diffuse disease of
the epicardial conduit vessel here refers to nonob-
structive atherosclerotic disease with irregular lumi-
nal surfaces or mild stenoses that raise the resistance
to high-velocity flows and attenuate the hyperemic
response. This resistance to high-velocity flow
causes a progressive fall in coronary pressure along
the epicardial artery, which in 1 study averaged 10
mm Hg, that translates into an average FFR of 0.89
(13). In isolated microvessel disease, due to remod-
eling or rarefication, however, distal coronary pres-
sure is presumably maintained so that the FFR
approaches unity, yet responses to vasodilator stim-
uli are impaired and maximum hyperemia cannot be
achieved (8). Immediate post-PCI measurements of
the FFR lend support to the investigators’ assump-
tion of a coexistence of diffuse conduit vessel and
microvessel disease with focal coronary stenosis. For
example, the FFR measured immediately after suc-
cessful PCI remained in about one-third of all
patients 0.9 (14); that is, the average value found
in diffusely diseased epicardial conduit vessels (13).
If the claim of these investigators is correct, then
the widely employed FFR threshold of 0.75 to 0.80
for an ischemia-inducing lesion underestimates the
true functional significance of a coronary stenosis,
although they acknowledge its clinical value in
“populations with sufficient (multivessel) diffuse
disease.” On the basis of findings obtained with
their theoretical model, Johnson et al. (10) develop
a conceptual framework that describes the interac-
tions between estimates of the FFR and diffuse
conduit and resistance vessel function as determi-
nants of vascular resistance. Such conceptual frame-
work has intriguing implications for image-based
approaches for detecting and characterizing CAD,
which the following examples in single-vessel and
in balanced CAD serve to illustrate.
Stress-induced defects in “normal coronary arteries.”
The diagnostic performance of stress-rest MPI with
single-positron emission computed tomography or
positron emission tomography is typically judged
against findings on invasive coronary angiography.
Greater than 50% or 70% focal stenoses are con-
sidered “obstructive” and, thus, are defined as func-
tionally significant. Accordingly, stress-induced
perfusion defects without an angiographic correlate
are defined as “false positives.” Yet, diffuse conduit
vessel disease without a focal stenosis but with a
FFR of only 0.75 for example, namely, below the
ischemia-inducing threshold (13), clearly can in-
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205duce a perfusion defect, especially when an ade-
quate level of hyperemia can be achieved. Hence,
stress-induced defects, even in the absence of ob-
structive stenoses, should be considered “true
positive.”
Normal MPI in advanced CAD. Balanced triple-vessel
disease frequently serves as explanation for an ap-
parently normal MPI in patients with advanced
CAD. Such explanation assumes that obstructive
CAD is of similar severity comparable in all coro-
nary vessels. However, there may be another equally
plausible explanation: diffuse but nonobstructive
atherosclerosis and microvessel disease. Accord-
ingly, even in the presence of an angiographic
“obstructive stenosis,” the vasodilator response is
severely impaired and insufficient to produce a
trans-stenotic pressure gradient, so that the FFR
approaches unity while, paradoxically, the CFR is
low as the hyperemic flow response is markedly
diminished, and the relative distribution of myocar-
dial blood flow remains unchanged from stress to
rest.
As both scenarios suggest, even though values for
CFR and FFR are at opposing ends of the normal
to abnormal spectrum, when combined, they more
adequately reflect the functional impact of advanced
coronary atherosclerosis. Thus, as Johnson et al.
(10) conclude, the disparity between different mea-
sures of stenoses significance cannot be explained byHeyndrickx GR. Relation between lesions. Circulationcoronary pathophysiology. The disparity between
FFR and CFR also has implications and offers
opportunities for therapy targeting and for moni-
toring therapy responses. For example, decreases in
stress perfusion defects associated with aggressive
treatments are typically ascribed to improvements in
stenosis severity. Yet, one could envision also an
increase in perfusion defect size and severity as an
indicator of treatment success; if, for example, the
treatment strategy selectively improves the micro-
vascular reactivity, allowing higher levels of phar-
macologically stimulated hyperemia, then the trans-
stenotic pressure gradient is likely to increase for the
same focal stenosis and result in a lower FFRs.
Therefore, as also suggested by the researchers, com-
bining both measures of stenosis severity will result in
a more comprehensive characterization of the patho-
physiological state of a coronary artery. It would also
offer an opportunity for defining and therapeutic
targeting diffuse coronary atherosclerosis and mi-
crovessel disease, both highly prevalent in patients
with advanced CAD (15,16).
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